Progress in Mind Go to Progress in Mind Main channel featuring interviews, articles, congress highlights and much more. Go to channel
Lundbeck Institute Campus. Go to Lundbeck Institute Campus. Medical education resource center in psychiatry and neurology. Go to channel
Migraine Read time: 3 min Congress highlights Real world evidence for CGRP antibodies in migraine prevention In a topical symposium at #EAN2021, three speakers discussed what is new on targeting CGRP for... Content action menuShareTestTest 2Test 3
Migraine Read time: 3 min Congress highlights Prioritizing migraine prevention In an educational session at #EAN2021, Dr Pablo Irimia Sieira, University of Navarra, Spain,... Content action menuShareTestTest 2Test 3
Migraine Read time: 3 min Satellite symposium Migraine management conundrums—the data can help What is the best management for patients with migraine if they have cardiovascular disease or if... Content action menuShareTestTest 2Test 3
Alzheimer's Disease Read time: 2 min Congress highlights New more accessible and affordable techniques for identifying people at risk of Alzheimer’s disease In specialist clinics, cerebrospinal fluid biomarkers for Abeta1-42, Abeta1-40, tTau, and pTau or... Content action menuShareTestTest 2Test 3
Migraine Read time: 3 min Congress highlights Real world evidence for CGRP antibodies in migraine prevention In a topical symposium at #EAN2021, three speakers discussed what is new on targeting CGRP for... Content action menuShareTestTest 2Test 3
Migraine, Alzheimer's Disease Read time: 2 min Congress highlights Highlights from EAN 2021 — Day 2 The exciting live and connected virtual experience for presenters and attendees of the 7th Congress... Content action menuShareTestTest 2Test 3
Migraine Read time: 3 min Congress highlights Do preventive anti CGRP treatments have a role in the acute migraine attack? Antibodies against the sensory neuropeptide calcitonin gene‑related peptide (CGRP) are showing... Content action menuShareTestTest 2Test 3
Migraine, Alzheimer's Disease Read time: 2 min Congress highlights Highlights from EAN 2021 — Day 1 Welcome to Progress in Mind’s live coverage of EAN 2021. This 7th Congress of the European... Content action menuShareTestTest 2Test 3
Migraine Read time: 2 min Congress highlights Can chronic migraine be prevented by targeting risk factors? Many risk factors have been identified for predicting the transition from episodic to chronic... Content action menuShareTestTest 2Test 3
Migraine Read time: 2 min Congress highlights Preventive therapy reduces interictal burden of migraine The impact of migraine on a person’s life is multi-faceted; not only is there substantial... Content action menuShareTestTest 2Test 3
Migraine Read time: 2 min Congress highlights Steps towards improving quality of life for patients with migraine Is it necessary to consider both patients and treating physicians’ views when investigating... Content action menuShareTestTest 2Test 3
Migraine Read time: 2 min Congress highlights Who should have migraine preventive treatment and how effective are these therapies? Migraine preventive therapy is used to reduce frequency, duration, or severity of attacks of... Content action menuShareTestTest 2Test 3